Formaldehyde treatment of proteins can constrain presentation to T cells by limiting antigen processing.
Proteins to be used as vaccines are frequently treated with formaldehyde, although little is known about the effects of this treatment on protein antigenicity. To investigate the effect of formaldehyde treatment on antigen recognition by T cells, we compared the in vitro T-cell response to proteins that have been formaldehyde treated with the response to untreated proteins. We found that peripheral blood mononuclear cells from individuals vaccinated with three formaldehyde-treated proteins (pertussis toxin, filamentous hemagglutinin, pertactin) of Bordetella pertussis showed little or no response to the formaldehyde-treated proteins but proliferated very well in response to the corresponding untreated protein. These findings were further confirmed with CD4+ T-cell clones specific for defined epitopes of the bacterial proteins. We found that some epitopes are presented poorly or not at all when formaldehyde-treated proteins are used, whereas other epitopes are equally presented to T-cell clones when either formaldehyde-treated or untreated antigens are used. However, T-cell recognition could be restored by either antigen degradation before formaldehyde treatment or heat denaturation after such treatment. Parallel digestion with trypsin of both formaldehyde-treated and untreated proteins showed that fragments generated from the two forms of the same antigen were different in size. These results demonstrate that formaldehyde treatment can constrain antigen presentation to T cells and that this may be due to an altered proteolytic processing of formaldehyde-treated proteins.
di Tommaso
A
A
Immunobiology Research Institute Siena, Italy.
de Magistris
M T
MT
Bugnoli
M
M
Marsili
I
I
Rappuoli
R
R
Abrignani
S
S
D000328:Adult; D017951:Antigen Presentation / Q000187:drug effects*; D001425:Bacterial Outer Membrane Proteins / Q000276:immunology; D002478:Cells, Cultured; D000939:Epitopes; D005557:Formaldehyde / Q000494:pharmacology*; D006388:Hemagglutinins / Q000276:immunology; D006801:Humans; D037342:Pertussis Toxin; D013601:T-Lymphocytes / Q000276:immunology*; D010566:Virulence Factors, Bordetella / Q000276:immunology
D001425:Bacterial Outer Membrane Proteins; D000939:Epitopes; D006388:Hemagglutinins; D010566:Virulence Factors, Bordetella; D005557:Formaldehyde; C068929:pertactin; D037342:Pertussis Toxin